N-methyl amisulpride (LB-102) / LB Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
N-methyl amisulpride (LB-102) / LB Pharma
NCT04187560: Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults

Completed
1
64
US
LB-102, Active Drug
LB Pharmaceuticals Inc.
Schizophrenia
07/20
11/20
NCT04588129: Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers

Completed
1
16
US
LB-102
LB Pharmaceuticals Inc., Washington University School of Medicine
Schizophrenia
09/21
11/21

Download Options